Clinical Trial Update: Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating the immunogenicity and safety of the bivalent oral poliovirus vaccine (types 1 and 3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• bivalent oral poliovirus vaccine (types 1 and 3) (bivalent OPV (types 1 and 3))

Snippet

Sponsor: Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED